CompletedPhase 4

Efficacy Study of Botox to Treat Neuropathic Pain

France29 participantsStarted 2004-06

Plain-language summary

Objectives : to investigate the analgesic effects and safety of intradermal botulinum toxin A injection in the treatment of focal painful neuropathies (eg, postherpetic neuralgia, nerve trauma)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * daily pain for at least 6 months of at least moderate intensity clearly attributed to the nerve lesion * limited area of pain * mechanical allodynia in the painful area Exclusion Criteria: * contraindication to BTXA formulation * coagulation disorders * another painful condition * current major depression * history of drug or alcohol abuse * compensation claim or litigation * facial neuropathic pain

What they're measuring

Self-reported pain (numerical scales) on patients diaries

Timeframe: prospective

Trial details

NCT IDNCT00527202

SponsorHospital Ambroise Paré Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-03

View on ClinicalTrials.gov More Postherpetic Neuralgia trials